The global market environment for biopharmaceuticals / pharmaceuticals is extremely competitive and is subject to increasing pricing pressure from payers and consumers.
Companies must be able to move quickly to identify technology opportunities, assess their value, and develop effective commercialization and reimbursement strategies.
Boston Healthcare supports drug companies (including specialty pharma and orphan drugs) with reimbursement and market access services, pricing and market analytics, business development support that capture value in a fluid and challenging environment.
- Health Economic Strategy Development
- Pricing and Reimbursement Infrastructure Strategy (including for specialty and orphan drugs)
- Literature and Guideline Review
- Primary Stakeholder Research
- Coverage, Coding, and Payment Research
- Review of P&T Formulary Placement
- Value dossiers / publications